18-β Glycyrrhetinic acid alleviates 2-acetylaminofluorene-induced hepatotoxicity in Wistar rats: Role in hyperproliferation, inflammation and oxidative stress.
S K Hasan, R Khan, N Ali, A Q Khan, M U Rehman, M Tahir, A Lateef, S Nafees, S J Mehdi, S Rashid, A Shahid, S Sultana
Index: Hum. Exp. Toxicol. 34 , 628-41, (2015)
Full Text: HTML
Abstract
2-Acetylaminofluorene (2-AAF) is a known hepatic carcinogen which leads to tumour formation in rodents. 18-β Glycyrrhetinic acid (18β-GA) derived from liquorice plant has various pharmacological properties such as anti-ulcer, anti-inflammatory, antiviral, hepatoprotective and antioxidant. This study is designed to elucidate the chemopreventive properties of 18β-GA against 2-AAF-induced liver toxicity in Wistar rats and evaluated its effect on inflammatory and tumour promotion marker and activities of different oxidative stress enzymes. Administration of 2-AAF at the dose of (50 mg/kg body weight (b.w.) intraperitoneally (i.p.)) for five consecutive days induces hepatic toxicity, inflammation, oxidative stress and hyperproliferation. Pretreatment with 18β-GA at two different doses (45 and 75 mg kg(-1) b.w.) significantly ameliorates 2-AAF-induced increased lipid peroxidation, alanine transaminase and aspartate transaminase, xanthine oxidase activities and activities of phase-II detoxifying enzymes along with the levels of glutathione content. Administration of 18β-GA also significantly restored the expressions of proliferating cell nuclear antigen, cyclooxygenase 2, inducible nitric oxide synthase and nuclear factor κB. Furthermore, histological observations also support the preventive effects of 18β-GA. Our findings suggest that pretreatment with 18β-GA showed potential hepatoprotective effects via attenuation of oxidative stress, inflammation and hyperproliferation. © The Author(s) 2014.
Related Compounds
Related Articles:
2015-06-01
[Cell Biochem. Funct. 33 , 202-10, (2015)]
2015-10-27
[ACS Nano 9 , 9994-10004, (2015)]
[Iran. J. Pharm. Res. 14(2) , 395-405, (2015)]
2015-02-15
[Toxicol. Appl. Pharmacol. 283(1) , 65-74, (2015)]
2015-06-01
[Drug Res. (Stuttg.) 65 , 281-6, (2015)]